Morphic partners with investor AbbVie on integrin inhibitor development
The Waltham, Massachusetts-based company will receive $100 million, in addition to potential undisclosed milestones and royalties.
integrin inhibitors
The Waltham, Massachusetts-based company will receive $100 million, in addition to potential undisclosed milestones and royalties.